Dealing with Nightmare Epileptic Dogs and Cats

Rating:
Webinar rating:
Published on: 21.05.2014

Presenter:

Dr Laurent Garosi DVM Dip ECVN MRCVS
RCVS & European Specialist in Veterinary Neurology
Head of Neurology/Neurosurgery- Davies Veterinary Specialists

Add to favorites

About The Webinar

Seizures are aetiologically categorised as idiopathic, symptomatic or reactive. Idiopathic epilepsy is the most common cause in dogs and cats. The main aims of antiepileptic treatment are to reduce the frequency and severity of seizures while minimising potential side effects and optimising the owner’s and dog’s quality of life. Most epileptic dogs are treated pharmacologically successfully for life with phenobarbitone. However, about 20 – 30% of treated dogs are reported to either be poorly responsive to phenobarbitone and/or suffer unacceptable side effects and toxicity. In patients with apparent refractory epilepsy, it is essential to search for errors in diagnosis or management that may be responsible for treatment failure. This presentation proposes a step-wise approach to suspected refractory epileptic patients.

CPD/CE Tracker

When you have watched the webinar, click on the 'Add To Tracker' button below. This will add a record to your CPD Tracker dashboard located in the main menu under 'My Membership'. Complete the reflective learning fields for future reference. When you click 'update' the information is saved. You can edit this information at a later date either on the webinar page or in your CPD Tracker dashboard. We recommend you download your record regularly for safekeeping.